PHOENIX Pharma Belgium SA
496.7 FTEPHOENIX Pharma Belgium reported revenue of €1.33bn for the 2026 financial year (annual accounts filed with the NBB on 25 Jun 2026), with 496.7 full-time equivalents.
The score of PHOENIX Pharma Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Revenue +20 % Equity +148 % Total assets +7 % Headcount (avg FTE) -11 %
Accounts of the company itself (not consolidated).
The full file covers 17 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PHOENIX Pharma Belgium's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | €1.33bn | ||||
| Net result | €3.81m | ||||
| Equity | €46.5m | ||||
| Cash | 56,425 € | ||||
| EBITDA | €9.13m | ||||
| Total assets | €235.4m |
Filed annual accounts
- Year ended 31 Jan 2026filed on 25 Jun 2026
- Year ended 31 Jan 2025filed on 07 Jul 2025
- Year ended 31 Jan 2024filed on 04 Jul 2024
- Year ended 31 Mar 2023filed on 11 Oct 2023
- Year ended 31 Mar 2022filed on 07 Oct 2022
PHOENIX Pharma Belgium's financial analysis
- Solvency19.8%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PHOENIX Pharma Belgium
PHOENIX Pharma Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0425.353.116
- VAT number
- BE0425353116
- Peppol
- Registered · 0208:0425353116 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Dec 1983
- Registered office
- 1200 Woluwe-Saint-Lambert
- Size
- Large · 496.7 FTE
- Latest accounts
- 2026 · filed on 25 Jun 2026
- Activity
- Manufacture of medicaments (NACE 21201)
PHOENIX Pharma Belgium (SA) has been based in Woluwe-Saint-Lambert since 1983, active in: manufacture of medicaments. For 2026, it reports revenue of €1.33bn, a net profit of €3.81m and equity of €46.5m. With 496.7 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 19.8%, below the median of its sector (41.4%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to PHOENIX Pharma Belgium
Companies in the same business, of comparable size and area, outside its group.
- SERB Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €159.3m
- Roche Manufacture of pharmaceutical preparations Anderlecht · balance sheet €164.7m
- Nipro Medical Europe Wholesale of pharmaceutical and medical goods Mechelen · balance sheet €324.7m
- Sanofi Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €218.9m
- Novartis Pharma Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €168.8m
- EG Wholesale of pharmaceutical and medical goods Brussels · balance sheet €113.6m
- Vertex Pharmaceuticals (Belgium) Wholesale of pharmaceutical and medical goods Brussels · balance sheet €84.4m
- Fresenius Kabi Wholesale of pharmaceutical and medical goods Schelle · balance sheet €90.3m
Frequently asked questions about PHOENIX Pharma Belgium
What is the revenue of PHOENIX Pharma Belgium?
According to the 2026 annual accounts filed with the NBB, the revenue of PHOENIX Pharma Belgium amounts to 1,325,431,123 €.
What is the VAT number of PHOENIX Pharma Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0425353116 for PHOENIX Pharma Belgium, if the company is VAT-registered. Its company number (CBE) is 0425.353.116.
Where is the registered office of PHOENIX Pharma Belgium?
According to the CBE register, the registered office of PHOENIX Pharma Belgium is in 1200 Woluwe-Saint-Lambert.
What is the equity of PHOENIX Pharma Belgium?
At the close of the 2026 financial year, the equity of PHOENIX Pharma Belgium amounts to 46,544,351 €, a solvency of 19.8% of total assets.
How many people work at PHOENIX Pharma Belgium?
496.7 full-time equivalents on average according to the 2026 social balance sheet.
Who manages PHOENIX Pharma Belgium?
The register lists 3 active mandates at PHOENIX Pharma Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PHOENIX Pharma Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →